{"url":"https://lda.senate.gov/api/v1/filings/6b4772f7-d05f-477d-9d66-e1d164e8da92/","filing_uuid":"6b4772f7-d05f-477d-9d66-e1d164e8da92","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2024,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/6b4772f7-d05f-477d-9d66-e1d164e8da92/print/","filing_document_content_type":"text/html","income":"60000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Bobby McMillin","dt_posted":"2024-07-18T13:07:25-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"601 Massachusetts Ave. NW","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":4301,"url":"https://lda.senate.gov/api/v1/registrants/4301/","house_registrant_id":31381,"name":"ARNOLD & PORTER KAYE SCHOLER LLP","description":"Law firm","address_1":"601 Massachusetts Ave. NW","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"NICHOLAS TOWNSEND","contact_telephone":"+1 202-942-5249","dt_updated":"2026-07-23T17:01:48.496438-04:00"},"client":{"id":56054,"url":"https://lda.senate.gov/api/v1/clients/56054/","client_id":56054,"name":"GENETIX BIOTHERAPEUTICS, INC.","general_description":"Biotechnology and pharmaceutical company.","client_government_entity":null,"client_self_select":false,"state":"MA","state_display":"Massachusetts","country":"US","country_display":"United States of America","ppb_state":"MA","ppb_state_display":"Massachusetts","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2023-05-01"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues and legislation related to access to gene therapies and treatment of rare diseases; the Medicaid VBPs for Patients (MVP) Act (H.R. 2666); Creating Hope Reauthorization Act (H.R. 7384 / S. 4583); Legislation related to antikickback exclusions for travel and lodging arrangements between manufacturers of drugs and patients","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":63646,"prefix":null,"prefix_display":null,"first_name":"EUGENIA","nickname":null,"middle_name":null,"last_name":"PIERSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":102193,"prefix":null,"prefix_display":null,"first_name":"BOBBY","nickname":null,"middle_name":null,"last_name":"MCMILLIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140808,"prefix":null,"prefix_display":null,"first_name":"SONJA","nickname":null,"middle_name":null,"last_name":"NESBIT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142893,"prefix":null,"prefix_display":null,"first_name":"LEIGH","nickname":null,"middle_name":"ANN","last_name":"FAIRLEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142892,"prefix":null,"prefix_display":null,"first_name":"LUKE","nickname":null,"middle_name":null,"last_name":"ALBERT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141979,"prefix":null,"prefix_display":null,"first_name":"RON","nickname":null,"middle_name":null,"last_name":"KIND","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues and legislation related to access to gene therapies and treatment of rare diseases; the Medicaid VBPs for Patients (MVP) Act (H.R. 2666); Creating Hope Reauthorization Act (H.R. 7384 / S. 4583); Legislation related to antikickback exclusions for travel and lodging arrangements between manufacturers of drugs and patients","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":63646,"prefix":null,"prefix_display":null,"first_name":"EUGENIA","nickname":null,"middle_name":null,"last_name":"PIERSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":102193,"prefix":null,"prefix_display":null,"first_name":"BOBBY","nickname":null,"middle_name":null,"last_name":"MCMILLIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140808,"prefix":null,"prefix_display":null,"first_name":"SONJA","nickname":null,"middle_name":null,"last_name":"NESBIT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142893,"prefix":null,"prefix_display":null,"first_name":"LEIGH","nickname":null,"middle_name":"ANN","last_name":"FAIRLEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142892,"prefix":null,"prefix_display":null,"first_name":"LUKE","nickname":null,"middle_name":null,"last_name":"ALBERT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141979,"prefix":null,"prefix_display":null,"first_name":"RON","nickname":null,"middle_name":null,"last_name":"KIND","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}